Alternatives to antibiotics – a pipeline portfolio review

by Lloyd Czaplewski, Richard Bax, Martha Clokie et al.
Lancet Infect Dis 2016 – Published Online: 12 January 2016

13 pp. 146 kB
http://www.lancet.com/pdfs/journals/laninf/PIIS1473-3099(15)00466-1.pdfcov200h_resize

Antibiotics have saved countless lives and enabled the development of modern medicine over the past 70 years. However, it is clear that the success of antibiotics might only have been temporary and we now expect a long-term and perhaps never-ending challenge to find new therapies to combat antibiotic-resistant bacteria. A broader approach to address bacterial infection is needed. In this Review, the authors discuss alternatives to antibiotics, which they defined as non-compound approaches (products other than classic antibacterial agents) that target bacteria or any approaches that target the host. The most advanced approaches are antibodies, probiotics, and vaccines in phase 2 and phase 3 trials.

(Visited 92 times, 1 visits today)
This entry was posted in Essential Medicines, General. Bookmark the permalink.